ElectroCyt, a technology startup from the University of Illinois at Urbana-Champaign, has been awarded $5,000 in Stage 1 of the VentureWell student grant program. The ElectroCyt team has created a sepsis diagnostic tool that will improve accuracy when diagnosing. Sepsis—a life-threatening condition is responsible for millions of deaths worldwide. It occurs when harmful bacteria and their toxins enter the bloodstream through open wounds and trigger inflammatory responses throughout the body. ElectroCyt is a faster and more accurate diagnostic tool than current methods—potentially saving many lives as well as billions in healthcare costs.